Metastasis Research Society (MRS)

The MRS is:
• An international professional society founded in 1984
• Open to all stakeholders in metastasis research and treatment from any country
• A registered 501(c)3 non-profit in the USA, headquartered in Tampa, FL
• Run enirely by volunteers around the world with the exception of one employee in the US

Mission:
The MRS is dedicated to promoting the furtherance of research into all aspects of metastasis, and the exchange of metastasis-related information amongst all key stakeholders in metastasis research and treatment including scientists, clinicians, and patients. These objectives are achieved through the following aims:
• Providing a forum that promotes interactions, collaborations and information exchange between pre-clinical, clinical and pharmaceutical company researchers world-wide through the organization of international conferences and networking events
• Encouraging outstanding patient-centered metastasis research with four biennial awards
• The publication of high quality, peer-reviewed research papers and reviews in the official journals of the society, Clinical and Experimental Metastasis and Cancer and Metastasis Reviews
• Fostering the career development of young investigators through the Early Career Ambassadors of the MRS lead by the Early Career Leadership Council of the MRS
• Increasing awareness of the importance of metastasis research and the need for increased financial support in this field worldwide
• Building and supporting partnerships with patient advocacy groups and members of the metastatic cancer patient community
• Working with Supporting Members (patients/friends etc.) to ensure metastasis research and treatment is patient-centered
• Educating the metastatic patient community to enable them to make informed treatment choices and participate in patient-centered research development